Unlocking
the future
of medicine

About us

Offering an unrivalled modular platform and tailored hyper-targeting is how we stand apart

Pipeline

Reducing the impact of cancer and infectious diseases on people’s lives is why we’re here

Innovation and research

Pushing the boundaries of human advancement in medicine is what drives us every day

Investors
 
 
 

A vaccine platform that unlocks unlimited possibilities for the future of medicine

The Nykode Therapeutics platform is built around the Vaccibody molecule. Inducing fast, strong and long-lasting immune responses, and demonstrating a positive safety profile, our pioneering Vaccibody™ vaccine has the potential to treat many disease areas, including cancer.

Highlights

Capital Markets Day in Oslo on May 12, 2022 ...

Read More
12 May 2022

Nykode Therapeutics – Interim results from Phase 2 trial ...

Read More
09 May 2022

Nykode Therapeutics announces positive interim results from its Phase ...

Read More
09 May 2022

Nykode Therapeutics – Invitation to Capital Markets Day in ...

Read More
06 May 2022

Kempen Life Sciences Conference – April 20, 2021

Read More
20 April 2022

Nykode Therapeutics to present at Kempen Life Sciences Conference

Read More
19 April 2022

Nykode Therapeutics to host Capital Markets Day

Read More
19 April 2022

Nykode Therapeutics announces presentation of preclinical data from its ...

Read More
08 April 2022

Nykode Therapeutics – full year 2021 financial results and ...

Read More
01 April 2022